美国 - 英文 - NLM (National Library of Medicine)

marc glassman, inc. - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg - antidiarrheal/antacid ■ controls diarrhea    ■ relieves heartburn, indigestion, nausea and upset stomach

美国 - 英文 - NLM (National Library of Medicine)

par pharmaceutical, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may

美国 - 英文 - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori  has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may

加拿大 - 英文 - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - bismuth subsalicylate - suspension - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents

加拿大 - 英文 - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - bismuth subsalicylate - suspension - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents

加拿大 - 英文 - Health Canada

technilab pharma inc. - bismuth subsalicylate - liquid - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents

加拿大 - 英文 - Health Canada

perrigo international - bismuth subsalicylate - suspension - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents

加拿大 - 英文 - Health Canada

wes pak products ltd. - bismuth subsalicylate - suspension - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents

加拿大 - 英文 - Health Canada

vita health products inc - bismuth subsalicylate - tablet - 262mg - bismuth subsalicylate 262mg - antidiarrhea agents

加拿大 - 英文 - Health Canada

jamp pharma corporation - bismuth subsalicylate - tablet - 262mg - bismuth subsalicylate 262mg - antacids and adsorbents